today the Senate passed the Stem Cell Therapeutic and Research Reauthorization Act of 2010. I was pleased to have been involved in the crafting of this bill, which is the product of months of bipartisan discussions, collaboration, and negotiation. I also want to recognize the hard work and dedication of Senators Dodd, Hatch, Burr, and Ensign in getting this bill across the finish line in the Senate. This bill offers promise to the tens of thousands of individuals diagnosed with leukemia and lymphomas, sickle cell anemia, and rare genetic blood disorders. It will reauthorize the C.W. Bill Young National Marrow Donor Program, which has been helping to connect individuals in need of a bone marrow transplant with donors since 1986, and the National Cord Blood Inventory, which has been helping to connect individuals in need of an umbilical cord blood transplant with donors since 1999. I am particularly pleased that the bill will remove a cap on the number of cord blood units that could be stored by qualified cord blood banks in the National Cord Blood Inventory.
Editor's note · Context
The speaker discusses the passage of the Stem Cell Therapeutic and Research Reauthorization Act of 2010.
Share
More from Jack Reed
for 4 months, my Democratic colleagues and I have come to the floor to warn against President Trump's military operations in South and Central America. We pointed out that his boat-strike campaign was strategically incoherent, legally…
I will not. But this is not the way the bill works. If you review the specific page and line that Senator Lee has referenced, page 14, line 15, and just look a few lines further in that same direction--specifically page 15, line 6--the…
Ultimately, this is all about helping patients and families in their time of need as they face unimaginable circumstances. It provides direct support to these critical institutions that do incredible research, match donors and patients…
Vague generalities are not helping this committee make critical judgments.





